GP0357D Hereditary Angiodema in the US

IQVIATM (, a healthcare research firm, is currently conducting a research study with individuals who have HAE (Type I or II). Participation involves a one-time telephone interview lasting 90 minutes to answer questionnaires and provide your feedback. In appreciation of your time, we will provide compensation.  

This research will focus on understanding the experience of people with HAE who can speak about their HAE attack experience. This research may help improve how the patient experience is accounted for in clinical trials. 

The interviews are aiming to be scheduled from October through November 2021 and we have a range of different time slots available to accommodate your schedule.

The study results will strictly be used for research purposes and these will absolutely not be used for sales or promotional purposes or activities.

If you are interested, please contact

Join this Study
Are you already a member of Global Patients?